Correction to: Ruxolitinib therapy formyelofibrosis in Austria

The original version of this article unfortunately contained a mistake. Table Nr. 1 was inconsistent. The corrected version of Table 1 is given below. We apologize for any inconveniences this may have caused.

Table 1 World Health Organisation (WHO) diagnostic criteria for PMF. (Table adjusted from [20])

Full size table

Author information

Authors and Affiliations

Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University Vienna, Vienna, Austria
Maria-Theresa Krauth & Heinz Gisslinger
Department of Internal Medicine IV, Klinikum Wels-Grieskirchen, Wels, Austria
Sonja Burgstaller
Department of Internal Medicine I, Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Ordensklinikum Linz-Elisabethinen, Linz, Austria
Veronika Buxhofer-Ausch & Andreas Petzer
Department of Internal Medicine V, Division Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
Günther Gastl
Fifth Medical Department, Hospital Hietzing, Vienna, Austria
Klaus Geissler
Third Medical Department, Hanusch Hospital, Vienna, Austria
Felix Keil & Thamer Sliwa
Department of Internal Medicine, LKH Fürstenfeld, Krankenhausverbund Feldbach, Fürstenfeld, Austria
Peter Krippl
Third Medical Department, Division Hematology and Medical Oncology, Paracelsus Medical University Salzburg, Salzburg, Austria
Thomas Melchardt
Internal Medicine II, Medical Oncology, Hematology, Gastroenterology and Rheumatology, Academic Teaching Hospital Feldkirch, Feldkirch, Austria
Holger Rumpold
Permedio Center for Personalized Medicine and Sanatorium Hera Vienna, Vienna, Austria
Stefan Wöhrer
Division of Hematology, Medical University of Graz, Graz, Austria
Albert Wölfler

Authors

Maria-Theresa Krauth
View author publications
You can also search for this author in PubMed Google Scholar
Sonja Burgstaller
View author publications
You can also search for this author in PubMed Google Scholar
Veronika Buxhofer-Ausch
View author publications
You can also search for this author in PubMed Google Scholar
Günther Gastl
View author publications
You can also search for this author in PubMed Google Scholar
Klaus Geissler
View author publications
You can also search for this author in PubMed Google Scholar
Felix Keil
View author publications
You can also search for this author in PubMed Google Scholar
Peter Krippl
View author publications
You can also search for this author in PubMed Google Scholar
Thomas Melchardt
View author publications
You can also search for this author in PubMed Google Scholar
Andreas Petzer
View author publications
You can also search for this author in PubMed Google Scholar
Holger Rumpold
View author publications
You can also search for this author in PubMed Google Scholar
Thamer Sliwa
View author publications
You can also search for this author in PubMed Google Scholar
Stefan Wöhrer
View author publications
You can also search for this author in PubMed Google Scholar
Albert Wölfler
View author publications
You can also search for this author in PubMed Google Scholar
Heinz Gisslinger
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria-Theresa Krauth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krauth, MT., Burgstaller, S., Buxhofer-Ausch, V. et al. Correction to: Ruxolitinib therapy formyelofibrosis in Austria. Wien Klin Wochenschr 131, 47 (2019). https://doi.org/10.1007/s00508-018-1428-7

Download citation

Published: 12 December 2018
Issue Date: January 2019
DOI: https://doi.org/10.1007/s00508-018-1428-7

Use our pre-submission checklist

Avoid common mistakes on your manuscript.